David Farlow

576 total citations
33 papers, 415 citations indexed

About

David Farlow is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, David Farlow has authored 33 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 6 papers in Surgery. Recurrent topics in David Farlow's work include Medical Imaging and Pathology Studies (5 papers), Cutaneous Melanoma Detection and Management (4 papers) and Pediatric Urology and Nephrology Studies (4 papers). David Farlow is often cited by papers focused on Medical Imaging and Pathology Studies (5 papers), Cutaneous Melanoma Detection and Management (4 papers) and Pediatric Urology and Nephrology Studies (4 papers). David Farlow collaborates with scholars based in Australia, United States and Denmark. David Farlow's co-authors include George Larcos, S Gruenewald, V F Antico, Simon M. Gruenewald, Howard Gurney, Graham J. Mann, Rosemary L. Balleine, Laurent P. Rivory, Christine L. Clarke and Catherine A.B. Saunders and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and The American Journal of Cardiology.

In The Last Decade

David Farlow

32 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Farlow Australia 12 167 127 90 87 65 33 415
Yonghui Chen China 13 435 2.6× 114 0.9× 90 1.0× 160 1.8× 83 1.3× 72 654
R. Minervini Italy 13 299 1.8× 53 0.4× 29 0.3× 254 2.9× 35 0.5× 40 534
R. Hartenstein Germany 14 142 0.9× 124 1.0× 26 0.3× 261 3.0× 15 0.2× 59 582
Gary P. Kearney United States 12 184 1.1× 23 0.2× 64 0.7× 166 1.9× 24 0.4× 21 380
Nobuhiko Hyochi Japan 12 211 1.3× 38 0.3× 19 0.2× 132 1.5× 20 0.3× 29 345
Ron Rowbotham United States 12 308 1.8× 116 0.9× 19 0.2× 287 3.3× 32 0.5× 18 757
A. Cortesse France 13 209 1.3× 67 0.5× 64 0.7× 273 3.1× 40 0.6× 61 682
C M Dudiak United States 11 78 0.5× 22 0.2× 24 0.3× 191 2.2× 96 1.5× 20 452
Tatiana Cabrera Canada 12 135 0.8× 86 0.7× 30 0.3× 134 1.5× 61 0.9× 30 465

Countries citing papers authored by David Farlow

Since Specialization
Citations

This map shows the geographic impact of David Farlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Farlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Farlow more than expected).

Fields of papers citing papers by David Farlow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Farlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Farlow. The network helps show where David Farlow may publish in the future.

Co-authorship network of co-authors of David Farlow

This figure shows the co-authorship network connecting the top 25 collaborators of David Farlow. A scholar is included among the top collaborators of David Farlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Farlow. David Farlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Farlow, David, et al.. (2022). Tilmanocept as a novel tracer for lymphatic mapping and sentinel lymph node biopsy in melanoma and oral cancer. ANZ Journal of Surgery. 92(10). 2607–2612. 4 indexed citations
3.
Kwok, Fiona, et al.. (2022). Correlation of Quantitative 99mTc DPD Scintigraphy With Echocardiographic Alterations in Left Atrial Parameters in Transthyretin Amyloidosis. Heart Lung and Circulation. 31(6). 804–814. 2 indexed citations
4.
Fois, Alessandro F., Kevin London, Neil Mahant, et al.. (2021). Rest tremor correlates with reduced contralateral striatal dopamine transporter binding in Parkinson's disease. Parkinsonism & Related Disorders. 85. 102–108. 6 indexed citations
5.
Kwok, Fiona, et al.. (2021). Correlation Between Quantitative Uptake of 99mTC-DPD and Echocardiographic Parameters in Cardiac ATTR: A Novel Follow-Up Strategy. Frontiers in Cardiovascular Medicine. 8. 663929–663929. 3 indexed citations
6.
Farr, Katherina P., et al.. (2019). Functional perfusion image guided radiation treatment planning for locally advanced lung cancer. Physics and Imaging in Radiation Oncology. 11. 76–81. 11 indexed citations
7.
Wang, Wei, Dan Jia, T. B. Moodie, et al.. (2018). Location of arm draining lymph node in relation to breast cancer radiotherapy field and target volume. Radiotherapy and Oncology. 133. 193–197. 7 indexed citations
8.
Farlow, David, et al.. (2016). Utility of hybrid SPECT/CT in primary melanoma lymphoscintigraphy: A retrospective case series. Journal of Medical Imaging and Radiation Oncology. 61(2). 204–211. 4 indexed citations
9.
Farlow, David, et al.. (2016). SPECT/CT in Melanoma Lymphoscintigraphy. Clinical Nuclear Medicine. 41(12). 961–963. 5 indexed citations
10.
Gan, G., David Farlow, Jerome Laurence, et al.. (2012). Impact of F18‐fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours. ANZ Journal of Surgery. 82(3). 140–144. 10 indexed citations
11.
Evans, Stephen, Laurent P. Rivory, Janelle M. Hoskins, et al.. (2005). Hepatic technetium Tc 99m?labeled sestamibi elimination rate and () genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer. Clinical Pharmacology & Therapeutics. 77(1). 33–42. 49 indexed citations
12.
Spicer, S. Timothy, Brian J. Nankivell, George Larcos, et al.. (1999). Mercaptoacetyltriglycine diuretic renography and output efficiency measurement in renal transplant patients. European Journal of Nuclear Medicine and Molecular Imaging. 26(2). 152–154. 6 indexed citations
13.
Gruenewald, Simon M., et al.. (1999). Acute renal failure in critically ill patients: Evaluation of an ultrasound contrast agent. Australasian Radiology. 43(2). 180–184. 9 indexed citations
14.
Saunders, Catherine A.B., et al.. (1998). Assessment of Pediatric Hydronephrosis Using Output Efficiency. The Journal of Urology. 38(9). 1411–1412. 28 indexed citations
15.
Larcos, George, David Farlow, V F Antico, S Gruenewald, & John Boyages. (1994). The role of high dose 67‐gallium scintigraphy in staging untreated patients with lymphoma. Australian and New Zealand Journal of Medicine. 24(1). 5–8. 17 indexed citations
16.
Larcos, George, V F Antico, Wes Cormick, S Gruenewald, & David Farlow. (1994). How useful is ultrasonography in suspected acute osteomyelitis?. Journal of Ultrasound in Medicine. 13(9). 707–709. 21 indexed citations
17.
Larcos, George, et al.. (1993). The Significance of Isolated Gallium-67 Uptake in the Hilar Lymph Nodes of an Untreated Lymphoma Patient. Clinical Nuclear Medicine. 18(12). 1039–1041. 3 indexed citations
18.
Gruenewald, S, et al.. (1990). Diagnosis and treatment of antenatal uropathies. Journal of Paediatrics and Child Health. 26(3). 142–147. 10 indexed citations
19.
Farlow, David, et al.. (1989). Early image acquisition after administration of indium-111 platelets in clinically suspected deep venous thrombosis. The American Journal of Cardiology. 64(5). 363–368. 2 indexed citations
20.
Larcos, George, et al.. (1989). Atypical appearance of an hepatic hemangioma with technetium-99m red blood cell scintigraphy.. PubMed. 30(11). 1885–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026